Conformational Analysis of Clinically Active Anticonvulsant Drugs

Journal of Medicinal Chemistry

Volumn 29, Issue 4, 1986, Pages 562-572

  Wong, M G ^a   Defina, J A ^a   Andrews, P R ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLFLUNITRAZEPAM; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; NORMEPHENYTOIN; PHENACEMIDE; PHENOBARBITAL; PHENYTOIN;

3 ETHYL 3 PHENYLGLUTARIMIDE; 3 ETHYL 3 PHENYLSUCCINIMIDE; 5 ETHYL 5 PHENYL 2,4 OXAZOLIDINEDIONE; 5 ETHYL 5 PHENYL 2,4 PYRIMIDINEDIONE; 5,5 DIPHENYL 2,4 OXAZOLIDINEDIONE; ALPHA,ALPHA DIPHENYLSUCCINIMIDE; DIPHENYLACETYLUREA; DIPHENYLBARBITURIC ACID; DRUG COMPARISON; DRUG STRUCTURE; NONBIOLOGICAL MODEL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THEORETICAL STUDY;

ANTICONVULSANTS; BENZODIAZEPINES; DIAZEPAM; MODELS, STRUCTURAL; MOLECULAR CONFORMATION; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0022472943     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00154a022     Document Type: Article

References (115)

1. M. J. Eadie, Drugs, 27, 328 (1984).
2. D. M. Woodbury, J. K. Penry, and C. E. Pippenger, Eds., “Antiepileptic Drugs”, Raven Press, New York, 1982.
3. A. Chapman, P. E. Keane, B. S. Meldrum, J. Simiand, and J. C. Vernieres, Prog. Neurobiol., 19, 315 (1982).
4. E. J. Lien, J. Med. Chem. 13, 1189 (1970).
5. E. J. Lien, R.-C.H. Liao, and H. G. Shinouda, J. Pharm. Sci., 68, 463 (1979).
6. J. Lapszewicz, J. Lange, S. Rump, and K. Walczyna, Eur. J. Med. Chem., 13, 465 (1978).
7. P. R. Andrews, J. Med. Chem., 12, 761 (1969).
8. P. R. Andrews and A. S. Buchanan, Biochem. Pharmacol., 20, 1599 (1971).
9. P. R. Andrews and J. A. Defina, Int. J. Quantum Chem. Quantum Biol. Symp., 7, 297 (1980).
10. J. H. Poupaert, D. Vandervorst, P. Guiot, M. M. M. Moustafa, and P. Dumont, J. Med. Chem., 27, 76 (1984).
11. S. Cortes, Z.-K. Liao, D. Watson, and H. Kohn, J. Med. Chem., 28, 601 (1985).
12. G. Tunnicliff and J. A. Smith, Biochem. Biophys. Res. Commun., 91, 1018 (1979).
13. M. K. Ticku, Biochem. Pharmacol., 30, 1573 (1981).
14. M. K. Ticku and R. W. Olsen, Life Sci., 22, 1643 (1978).
15. A. Antoniadis, W. E. Muller, and U. Wollert, Neurophar-macol., 19, 121 (1980).
16. W. M. Burnham, L. Spero, M. M. Okazaki, and B. K. Madras, Can J. Physiol. Pharmacol., 59, 402 (1981).
17. R. W. Olsen and F. Leeb-Lundberg, Adv. Biochem. Psy-chopharm., 26, 93 (1981).
18. M. Willow, I. G. Morgan, and G. A. R. Johnston, Neurosci. Lett., 24, 301, (1981).
19. D. S. Shah, P. Chambon, and A. Guidotti, Neuropharm., 20, 1115 (1981).
20. T. Mennini and S. Garattini, Adv. Biochem. Psychopharm., 38, 189 (1983).
21. M. M. Airaksinen, Acta Neurol. Scand. (Suppl.)., 93, 31 (1983).
22. A. C. Bowling and R. J. DeLorenzo, Science (Washington, D.C.), 216, 1247 (1982).
23. J. H. Skerritt and G. A. R. Johnston, Neurochem. Res., 8, 1351 (1983).
24. C. Braestrup and R. F. Squires, Eur. J. Pharmacol., 48, 263 (1978).
25. D. W. Gallagher, P. Mallorga, and J. F. Tallman, Brain Res., 189, 209 (1980).
26. G. C. Schussler, J. Pharmacol. Exp. Ther., 178, 204 (1971).
27. L. H. Easson and E. Stedman, Biochem. J., 27, 1257 (1933).
28. N. Finch, R. Dziemian, J. Cohen, and B. G. Steinetz, Experientia, 31, 1002 (1975).
29. T. C. Butler and W. J. Waddell, J. Pharmacol. Exp. Therapy., 110, 120 (1954).
30. T. C. Butler and W. J. Waddell, J. Pharmacol. Exp. Therap., 113, 238 (1955).
31. E. Frommel, P. Gold-Aubert, and G. Fleury, Arch. Int. Pharmacodyn., 122, 15 (1959).
32. P. R. Andrews and L. C. Mark, Anesthesiol., 57, 314 (1982).
33. J. Knabe, H. P. Buch, and D. Reischig, Arch. Pharm. (Weinheim.), 317, 614 (1984).
34. P. C. Wells, A. Kupfer, J. A. Lawson, and R. D. Harbison, J. Pharm. Exp. Ther., 221, 590 (1982).
35. H. Mizuno, S. Terashima, K. Achiwa, and S.-I., Yamada, Chem. Pharm. Bull., 15, 1749 (1967).
36. R. Bosch, H. Bruckner, G. Jung, and W. Winter, Tetrahedron, 38, 3579 (1982).
37. E. A. Swinyard, J. E. P. Toman, J. Pharmacol. Exp. Ther., 100, 151 (1950).
38. C. C. Pfeiffer, Science (Washington, D.C.), 124, 29 (1956).
39. A. Camerman and N. Camerman, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem., B27, 2205 (1971).
40. A. Camerman and N. Camerman, J. Am. Chem. Soc., 94, 768 (1972).
41. A. Camerman and N. Camerman, Science (Washington, D. C.), 168, 1457 (1970).
42. A. Camerman and N. Camerman, Proc. Natl. Acad. Sci. U.S.A. 74, 1264 (1977).
43. J. K. Fawcett, N. Camerman, and A. Camerman, Can. J. Chem., 55, 3631 (1977).
44. A. Camerman and N. Camerman, Jerusalem Symp. Quantum Chem. Biochem., 7, 213 (1974).
45. A. Camerman and N. Camerman, In 14X-ray Crystallography and Drug Action”, A. S. Horn and C. J. De Ranter, Eds., Clarendon Press, Oxford, 1984, p 256.
46. A. Camerman and N. Camerman, Adv. Neurol., 27, 223 (1980).
47. A. Camerman and N. Camerman, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem., B37, 1677 (1981).
48. M. van der Meerssche, J. P. Declercq, G. Germain, R. Bouche, and M. Draguet-Brughmans, Bull. Soc. Chim. Belg., 91, 1979 (1982).
49. J. N. Lisgarten and R. A. Palmer, Acta Crystallogr. Sect. B: Struct. Crystallogr. Cryst. Chem., B36, 2345 (1980).
50. J. Caillet and P. Claverie, Acta Crystallogr,, Sect. B: Struct. Crystallogr. Cryst. Chem., B36, 2642 (1980).
51. S.-H. Kim, and A. Rich, Proc. Natl. Acad. Sci. U.S.A. 60, 402 (1968).
52. D. G. R. Yeates and R. A. Palmer, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem., B31, 1077 (1975).
53. J. P. Bideau, L. Marley, and J. Housty, C.R. Acad. Sci., Ser. C. 269, 549 (1969).
54. P. P. Williams, Acta Crystallogr. Sect. B: Struct. Crystal-logr. Cryst. Chem., B30, 12 (1974).
55. P. P., Williams, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem., B29, 1572 (1973).
56. T. Uno and N. Shimizu, Acta Crystallogr., Sect. B: Struct. Crystallogr., Cryst. Chem., B36, 2794 (1980).
57. D. Mastropaolo, A. Camerman, and N. Camerman, Mol. Pharmacol., 23, 273 (1983).
58. M. H. J. Koch, G. Germain, J. P. Declercq, and Y. Dusausoy, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B31, 2547 (1975).
59. P. R. Andrews, A. J. Jones, G. P. Jones, A. Marker, and E. A. Owen, Eur. J. Med. Chem.-Chim. Ther. 16, 145 (1981).
60. F. I. Carroll, A. H. Lewin, E. E. Williams, J. A. Berdasco, and C. G. Moreland, J. Med. Chem., 27, 1191 (1984).
61. E. Finner, H. Zeugner, and W. Milkowski, Arch. Pharm. (Weinheim), 317, 369 (1984).
62. G. P. Jones and P. R. Andrews, J. Med. Chem., 23, 444 (1980).
63. H. D. Holtje, Arch. Pharm. (Weinheim), 310, 650 (1977).
64. T. Blair and G. A. Webb, J. Med. Chem., 20, 1206 (1977).
65. B. Pullman, J. L. Coubeils, and Ph. Courriere, J. Theor. Biol., 35, 375 (1972).
66. M. H. J. Koch, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B29, 379 (1973).
67. E. Giglio, Nature, 222, 339 (1969).
68. P. R. Andrews and G. P. Jones, Eur J. Med. Chem., 16, 139 (1980).
69. W. Bolton, Acta Crystallogr., 16, 166 (1963).
70. J.-P. Bideau, P. V. Huong, and S. Toure, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B32, 481 (1976).
71. G. P. Jones and P. R. Andrews, J. Chem. Soc., Perkin Trans. 2, in press.
72. R. E. Cassady, and S. W. Hawkinson, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B38, 1646 (1982).
73. A. Terzis, S. E. Filippakis, and D. Mentzafos, Cryst. Struc. Commun., 10, 803 (1981).
74. A. Camerman, D. Mastropaolo, and N. Camerman, J. Am. Chem. Soc., 105, 1584 (1983).
75. D. Mootz, Acta Crystallogr., 19, 726 (1965).
76. T. J. Kistenmacher and G. D. Stucky, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B26, 1445 (1970).
77. R. E. Rosenfield and J. D. Dunitz, Helv. Chim, Acta, 61, 2176 (1978).
78. R. Mason, Acta Crystallogr., 14, 720 (1961).
79. G. Argay, K. Simon, and A. Kalman, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B39, 805 (1974).
80. A. A. Karapetyan, V. G. Andrianov, and Y. T. Struckov, Cryst. Struct. ICommun., 9, 417 (1980).
81. G. Argay and A. Kalman, Acta Crystallogr. Cryst. Chem. B29, 636 (1973).
82. R. N. Brown, Acta Crystallogr., 14, 711 (1961).
83. G. S. D. King, J. Chem. Soc. B, 1244 (1966).
84. S. Martinez-Carrero and S. Garcia-Blanco, An. Quim., 78, 185 (1982).
85. M. Bonamico, F. Coppola, and G. Giacomello, Gazz. Chim. Ital., 91, 193 (1961).
86. C. S. Petersen, Acta Chem. Scand., 23, 2389 (1969).
87. F. H. Allen and J. Trotter, J. Chem. Soc. B, 1073 (1971).
88. M. H. J. Koch and O. Dideberg, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B29, 369 (1973).
89. H. Fujiwara, R. L. Varley, and J. M. Van der Veen, J. Chem. Soc., Perkin Trans. 2, 547 (1977).
90. T. A. Hamor and I. L. Martin, Prog. Med. Chem., 20, 157 (1983).
91. J. F. Blount, R. I. Fryer, N. W. Gilman, and L. J. Todaro, Mol. Pharmacol., 24, 425 (1983).
92. T. A. Hamor and I. L. Martin, In “X-Ray Crystallography and Drug Action”; A. S. Horn and C. J. de Ranter, Eds., Clarendon Press, Oxford, 1984, p 275.
93. K. Kamiya, Y. Wada, and M. Nishikawa, Chem. Pharm. Bull., 21, 1520 (1973).
94. J. A. Pople and M. Gordon, J. Am. Chem. Soc., 89, 4253 (1967).
95. F. H. Allen and J. Trotter, J. Chem. Soc. B, 1073, 1971.
96. P. R., Andrews, D. J. Craik, and J. L. Martin, J. Med. Chem., 27, 1648 (1984).
97. H. A. Robertson, Prog. Neuropsychopharmacol. Biol. Psychiatry 7, 637 (1983).
98. C. Braestrup and M. Nielson, Handbook Psychopharmacol. 17, 285 (1983) and references therein.
99. G. H. Loew, J. R. Nienow, and M. Poulsen, Mol. Pharmacol., 26, 19 (1984).
100. P. A. Borea, Arzneim-Forsch. Drug Res., 34, 649 (1984).
101. C. Foddai, M. L. Ganadu, and G. Crisponi, Biochem. Pharmacol., 32, 3241 (1983).
102. M. Sarrazin, J. C. Sari, M. Bourdeaux-Pointer, and C. Briand, Mol. Pharmacol., 15, 71 (1979).
103. H.-H. Paul, H. Sapper and W. Lohmann, Biochem. Pharmacol, 29, 137, (1980).
104. H.-H. Paul, H. Sapper, and W. Lohmann, Z. Naturforsch., 33, 870 (1978).
105. G. M. Crippen, Mol. Pharmacol., 22, 11 (1982).
106. M. Williams, Prog. Neuropsychopharmacol. Biol. Psychiat., 8, 209, (1984).
107. P. R. Andrews and E. J. Lloyd, J. Pharm. Pharmacol., 35, 516 (1983).
108. E. J. Lloyd and P. R. Andrews, J. Med. Chem., in press.
109. E. A. Swinyard, J. T. Miyahara, and L. S. Goodman, J. Pharm. Sci., 52, 463 (1963).
110. R. Taylor, O. Kennard, and W. Versichel, J. Am. Chem. Soc., 105, 5761 (1983).
111. R. Taylor, O. Kennard, and W. Versichel, J. Am. Chem. Soc., 106, 244 (1984).
112. R. Taylor, O. Kennard, and W. Versichel, Acta Crystallogr., Sect. B: Struct. Crystallogr. Cryst. Chem. B40, 280 (1984).
113. T. F. Koetzle and M. S. Lehman, In “The Hydrogen Bond”, P. Schuster, G. Zundel, and C. Sandorfy, Eds., North Holland, Amsterdam, 1976, p. 459–468.
114. I. Olovsson and P.-G. Jonsson, Reference 114, pp 395–453.
115. P. W. Codding, T. A. Lee, and J. F. Richardson, J. Med. Chem. 27, 649 (1984).